ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,719, issued on April 15, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).
"Small molecule inhibitors of galectin-3" was invented by Chunjian Liu (Pennington, N.J.), David S. Yoon (Ambler, Pa.), Wei Wang (Princeton, N.J.), Jianxin Feng (Bensalem, Pa.), Bruce A. Ellsworth (Princeton, N.J.) and Alicia Regueiro-Ren (New Hope, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compounds of Formula (I), which inhibit Gal-3, and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods using and making such compounds and compositions."
The patent was filed on March 25, 2020, ...